细胞凋亡
流式细胞术
免疫印迹
细胞生长
骨肉瘤
细胞培养
癌症研究
小RNA
化学
报告基因
分子生物学
细胞生物学
生物
基因表达
基因
生物化学
遗传学
作者
Yi Shu,W. Ye,Yang Gu,Pengchao Sun
出处
期刊:Bratislavské lekárske listy
[AEPress]
日期:2018-01-01
卷期号:119 (01): 41-46
被引量:17
摘要
OBJECTIVE: This study aimed to investigate the exact role of miR-663b in osteosarcoma (OS) progression and further explore the underlying molecular mechanisms.MATERIALS AND METHODS: The miR-663b expression in human OS cell lines was determined by qRT-PCR, and the results suggested that miR-663b was highly expressed in human OS cells.TargetScan was used to predict the potential targets of miR-663b, and the prediction was confi rmed by dual-luciferase reporter assay.To investigate the role of miR-663b in OS, miR-663b was down-regulated in U2OS cells using miR-663b inhibitor.CCK8 and fl ow cytometry were preformed to investigate the proliferation and apoptosis of U2OS cells.Moreover, qRT-PCR and western blot analysis were performed to measure the mRNA and protein expression.RESULTS: We found that miR-663b directly targets TP73 and negatively regulates TP73 expression.MiR-663b inhibitor signifi cantly decreased the proliferation ability of U2OS cells, while the percentage of apoptotic cells was markedly increased.The level of Bcl-2 was notably inhibited by miR-663b inhibitor, while Bax expression was signifi cantly enhanced.Moreover, miR-663b down-regulation promoted p53 and p21 expression in U2OS cells.CONCLUSIONS: MiR-663b down-regulation represses proliferation and induces apoptosis in OS by targeting TP73.Therefore, we provide a potential therapeutic target for OS treatment (Fig. 6, Ref. 27).
科研通智能强力驱动
Strongly Powered by AbleSci AI